Comparison of roxithromycin with co-amoxiclav in patients with sinusitis

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. B, 1998, Pages 81-84

  Chatzimanolis, E ^a   Marsan, N ^a   Lefatzis, D ^a   Pavlopoulos, A ^a,b  

^a Dracopouleion Centre of Blood Donation   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ROXITHROMYCIN;

ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINUSITIS;

EID: 0031949699     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_2.81     Document Type: Article

References (21)

1. Naclerio, R. & Kennedy, D. (1997). Sinusitis: bench to bedside. Current findings, future directions. Journal of Allergy and Clinical Immunology 99, S829-48.
2. Reuler, J. B., Lucas, L. M. & Kumar, K. L. (1995). Sinusitis: a review for generalists. Western Journal of Medicine 163, 40-8.
3. Fairbanks, D. (1993). Inflammatory diseases of the sinus. Otolaryngologic Clinics of North America 26, 549-9.
4. Oppenheimer, R. W. (1992). Sinusitis: how to recognize and treat it. Postgraduate Medicine 91, 281-6.
5. Smith, B. R. & Le Frock, J. L. (1985). Amoxicillin-potassium clavulanate: a novel β-lactamase inhibitor. Drug Intelligence and Clinical Pharmacy 19, 415-20.
6. Neu, H. C., Wilson, A. P. R. & Grüneberg, R. N. (1993). Amoxicillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. Journal of Chemotherapy 5, 67-93.
7. De Rose, V., Ferrara, A., Mangiarotti, P., Nonis, A., Bertoletti, R., Gialdroni Grassi, G. et al. (1988). Penetration of roxithromycin in bronchial secretions. International Journal of Clinical Pharmacology Research 8, 107-10.
8. Nilson, O. G., Aamo, T., Zahlsen, K. & Svarna, P. (1991). Macrolide pharmacokinetics and dose scheduling of roxithromycin. Diagnostic Microbiology and Infectious Diseases 15, 715-65.
9. Karalus, N. C., Garrett, J. E., Lang, S. D. R., Scott, R. A., Leng, G. N., Kostalas, R. T. M. et al. (1994). Clinical and economic comparison of roxithromycin 150 mg twice daily vs amoxicillin 500 mg/clavulanic acid 125 mg three times daily for the treatment of lower respiratory tract infections in general practice. Drug Investigation 8, 179-90.
10. Periti, P., Mazzei, T., Mini, E. & Novelli, A. (1989). Clinical pharmacokinetic properties of the macrolide antibiotics. Clinical Pharmacokinetics 16, 261-82.
11. Puri, S. K. & Lassman, H. B. (1987). Roxithromycin: a pharmacokinetic review of a macrolide. Journal of Antimicrobial Chemotherapy 20, Suppl. B, 89-110.
12. Ridgway, G. L. (1987). A review of the in-vitro activity of roxithromycin against genital pathogens. Journal of Antimicrobial Chemotherapy 20, Suppl. B, 7-11.
13. Dewever, M. (1988). Determination of roxithromycin concentration in the mucosa of the maxillary sinus. British Journal of Clinical Practice 42, Suppl. 55, 81.
14. Young, R. A., Gonzalez, J. P. & Sorkin, E. M. (1989). Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37, 8-14.
15. Grassi, C., Bartucci, F. & Sassella, D. (1988). Efficacy and safety of roxithromycin in respiratory tract infections. British Journal of Clinical Practice 42, Suppl. 55, 104-6.
16. Higuera-Ramirez, F., Hidalgo, H. & the Cooperative Multicentre National Team. (1991). Multicenter study of the efficacy and tolerability of roxithromycin in the treatment of respiratory tract infections. Drug Investigation 3, Suppl. 3, 38-46.
17. de Campora, E., Camaioni, A., Leonardi, M., Fardella, P. & Fiaoni, M. (1992). Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. Diagnostic Microbiology and Infectious Diseases 15, Suppl. 4, 119S-22S.
18. Dautzenberg, B., Scheimberg, A., Brambilla, C., Camus, P., Godard, P., Guerin, J.-C. et al. (1992). Comparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid in lower respiratory tract infections. Diagnostic Microbiology and Infectious Diseases 15, Suppl. 4, 85S-90S.
19. Lousbergh, D., Jochems, G., Everaert, L. & Puttemans, M. (1992). Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections. Diagnostic Microbiology and Infectious Diseases 15, Suppl. 4, 91S-5S.
20. Blanc, F., D'Enfert, J., Fiessinger, S., Lenoir, A., Renault, M. & Rezvani, Y. (1987). An evaluation of tolerance of roxithromycin in adults. Journal of Antimicrobial Chemotherapy 20, Suppl. B, 179-83.
21. Musher, D. (1992). Infections caused by S. pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clinical Infectious Disease 14, 801-9.